Agency / Dark Spot Formula
PERSONALISED · CYCLED
The subscription cycles the hydroquinone off for you — two to three months on, then two months on a hydroquinone-free formula, switched automatically. After sixteen reviews of courses sold as open-ended subscriptions, somebody finally built the break into the billing.
Worth buying for a specific person with a specific problem. Read who.
ASSESSED ON 75% OF THE MODEL. 2 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.
Ask which actives you have been prescribed and whether your formula contains hydrocortisone — the product page does not name it.
The verdict
We have spent sixteen reviews making the same structural complaint: hydroquinone, topical steroids, topical antibiotics and time-limited oral courses all sold on rolling subscriptions whose default behaviour is continuation, when the drugs themselves require a stop. Agency has built the stop into the product. Their treatment plan runs two to three months on a hydroquinone formula, then two months on a hydroquinone-free one that still treats pigment, and the company switches the bottle automatically so the patient does not have to track it.
That is the single best structural decision we have found in this register, and it is not close. It converts the commercial model from the thing working against the pharmacology into the thing enforcing it. Every other company we have assessed leaves the cycling to a prescriber conversation the buyer may never have; this one makes it the default and explains why — long-term hydroquinone without breaks risks permanent discoloration.
The rest is consistent with what we found on this company's Future Formula. A full inactive ingredient list, including an antioxidant system of ascorbic acid, sodium bisulfite and BHT that is exactly what a hydroquinone preparation needs. Preservatives quoted to two decimal places. A realistic eight-to-twelve-week timeline. A survey claim that states its sample size and duration and calls itself a survey. And, for the first time in sixteen reviews, a published fill weight — 18 g — which finally makes cost per application computable.
Two things hold it back. Concentrations are personalised and no range is published, which matters more for hydroquinone than for anything else because concentration is what the ochronosis literature keys on. And the company's own support material indicates the hydroquinone formula also contains hydrocortisone — a topical corticosteroid that does not appear in the active list on the page you buy from. A steroid belongs on the label wherever the label is.
- The subscription cycles the hydroquinone off automatically — two to three months on, two months on a hydroquinone-free formula.
- The break formula still treats pigment, so the pause is not lost time.
- The company switches the bottle for you, so the cycling does not depend on the patient tracking it.
- Publishes a full inactive ingredient list, including an antioxidant system correct for hydroquinone.
- First product in sixteen reviews to publish a fill weight — 18 g — making cost per application computable.
- Preservative concentrations quoted precisely (benzoic acid 0.09%, sorbic acid 0.09%).
- Application technique specified: cotton swab for localised spots, fingertips for larger patches — which limits treated area.
- States a realistic eight-to-twelve-week timeline rather than a day-30 figure.
- The 79% claim states n (147) and duration (9–12 months) and calls itself a survey.
- No concentration or range published for the hydroquinone — the number the ochronosis literature keys on.
- Hydrocortisone appears in the company's support material but not in the product page's active list.
- Kojic acid concentration unpublished, despite contact dermatitis being its recognised primary risk.
- Resveratrol and green tea extract have a thin evidence base for pigmentation.
- The cycling schedule is explained in support material rather than on the product page, where it is the strongest selling point available.
Every active, assessed
- HydroquinonePERSONALISED — NOT STATED
Tyrosinase inhibitor — the most effective topical depigmenting agent in use
- BENCHMARK
- 4% conventional prescription strength; ochronosis reports cluster above 4%
- ASSESSMENT
- The right drug, correctly prescription-gated, and — uniquely in this register — cycled off automatically. The concentration remains unpublished, and for hydroquinone that is the number the safety literature keys on, so a published range would matter more here than anywhere else.
- HydrocortisoneNOT STATED, AND NOT LISTED ON THE PRODUCT PAGE
Topical corticosteroid — reduces irritation and augments depigmenting effect
- BENCHMARK
- Classic Kligman-type combinations pair hydroquinone with a corticosteroid
- ASSESSMENT
- Pharmacologically defensible and the cycling protocol handles the duration risk properly. But this appears in the company's support material rather than in the active list on the product page, and a topical steroid should be named where a buyer decides.
- Azelaic AcidPERSONALISED — NOT STATED
Tyrosinase inhibition with selectivity for hyperactive melanocytes; anti-inflammatory
- BENCHMARK
- 15%–20% standalone; lower in combination
- ASSESSMENT
- A sound inclusion and a sensible component of the hydroquinone-free break formula, since it treats pigment without the ochronosis question.
- Kojic AcidPERSONALISED — NOT STATED
Second, independent route to tyrosinase inhibition
- BENCHMARK
- European scientific opinion holds it safe as a lightening agent up to 0.7% in the finished product
- ASSESSMENT
- Reasonable alongside the others. It is the most common sensitiser in this class and contact dermatitis is its recognised risk, so its level is worth knowing and is not published.
- Resveratrol · Green Tea (EGCG)PERSONALISED — NOT STATED
Antioxidants with modest pigmentation activity
- BENCHMARK
- No established topical dose for pigmentation
- ASSESSMENT
- Supporting players with a thinner evidence base than the other three. Reasonable inclusions in a break formula; not the reason this product works.
| ACTIVE | CONC. | BENCHMARK | ASSESSMENT |
|---|---|---|---|
| HydroquinoneTyrosinase inhibitor — the most effective topical depigmenting agent in use | PERSONALISED — NOT STATED | 4% conventional prescription strength; ochronosis reports cluster above 4% | The right drug, correctly prescription-gated, and — uniquely in this register — cycled off automatically. The concentration remains unpublished, and for hydroquinone that is the number the safety literature keys on, so a published range would matter more here than anywhere else. |
| HydrocortisoneTopical corticosteroid — reduces irritation and augments depigmenting effect | NOT STATED, AND NOT LISTED ON THE PRODUCT PAGE | Classic Kligman-type combinations pair hydroquinone with a corticosteroid | Pharmacologically defensible and the cycling protocol handles the duration risk properly. But this appears in the company's support material rather than in the active list on the product page, and a topical steroid should be named where a buyer decides. |
| Azelaic AcidTyrosinase inhibition with selectivity for hyperactive melanocytes; anti-inflammatory | PERSONALISED — NOT STATED | 15%–20% standalone; lower in combination | A sound inclusion and a sensible component of the hydroquinone-free break formula, since it treats pigment without the ochronosis question. |
| Kojic AcidSecond, independent route to tyrosinase inhibition | PERSONALISED — NOT STATED | European scientific opinion holds it safe as a lightening agent up to 0.7% in the finished product | Reasonable alongside the others. It is the most common sensitiser in this class and contact dermatitis is its recognised risk, so its level is worth knowing and is not published. |
| Resveratrol · Green Tea (EGCG)Antioxidants with modest pigmentation activity | PERSONALISED — NOT STATED | No established topical dose for pigmentation | Supporting players with a thinner evidence base than the other three. Reasonable inclusions in a break formula; not the reason this product works. |
Scoring
- EVIDENCE FOR THE ACTIVEWEIGHT 30%62/100
Hydroquinone is grade-A for hyperpigmentation, azelaic acid has real support and kojic acid modest support; resveratrol and EGCG are thinner. More importantly, the cycling protocol reflects what the clinical literature actually says about hydroquinone duration. Held back by unpublished concentrations.
- FORMULATION INTEGRITYWEIGHT 20%75/100
The highest we have scored. The antioxidant system — ascorbic acid, sodium bisulfite, BHT — is precisely what hydroquinone needs to resist oxidation, and it is published rather than inferred. Preservatives are quoted to two decimals. And the protocol itself is part of the formulation thinking: a break formula that keeps treating pigment while the hydroquinone is paused. Marked down only because the corticosteroid is absent from the page's active list.
- DISCLOSUREWEIGHT 15%60/100
Full inactive list, a published 18 g fill weight — the first in sixteen reviews — a realistic eight-to-twelve-week timeline, an honestly framed survey claim with n and duration, and a cycling schedule explained in the support material. Against that: no concentration range for any active, and a topical steroid that appears in support material but not in the product page's ingredient list.
- TOLERANCE IN USEWEIGHT 15%NOT ASSESSED
Not assessed. Worth noting that the application instruction — cotton swab for localised spots, fingertips only for larger patches — limits treated area, which is one of the named risk factors in the ochronosis literature.
- TEXTURE & WEARWEIGHT 10%NOT ASSESSED
Not assessed. Requires the product in hand across a full on-and-off cycle.
- COST PER APPLICATIONWEIGHT 10%62/100
$35 a month for 18 g shipped every 60 days is the first pricing in this register where cost per gram is actually computable, because the fill weight is published. For a spot treatment applied by cotton swab, 18 g over 60 days is a realistic quantity.
What it is
Dark Spot Formula is a personalised compounded cream from Agency, a Curology brand, at $35 a month for 18 g shipped every 60 days. A dermatology provider selects actives from a pool including hydroquinone, kojic acid, azelaic acid, resveratrol and green tea extract. It is applied twice daily — by cotton swab for individual spots, or fingertips for larger patches.
The finding: the subscription enforces the break
Across sixteen reviews and three companies, the most consistent problem we have identified is not a formulation fault. It is that drugs requiring time-limited courses — hydroquinone, topical corticosteroids, topical antibiotics, twelve-week oral courses — are sold through subscriptions whose default behaviour is that they keep arriving.
Agency's treatment plan for this product runs two to three months on a hydroquinone formula, followed by two months on a hydroquinone-free formula that continues treating pigment. The company sends the correct bottle when it is time to switch, so the schedule does not depend on the patient remembering it. Their stated reason is the right one: long-term hydroquinone use without breaks risks permanent discoloration.
Every other hydroquinone product in this register is sold with no stated duration at all. This one stops on its own.
Everyone can agree hydroquinone should be cycled. The difference is who carries the burden. Every other company leaves it to a prescriber conversation the buyer may never have, inside a billing arrangement that quietly renews. This one makes the correct behaviour the default and the incorrect behaviour the thing you would have to go out of your way to arrange.
It also solves a second problem at the same time. The company's support material indicates the hydroquinone formula contains hydrocortisone — a corticosteroid, which is the classic partner for hydroquinone and is exactly the kind of thing that should not run indefinitely on facial skin. The same two-month break that protects against ochronosis is also a steroid holiday.
The disclosure keeps improving
We said of this company's Future Formula that it set the disclosure standard for this register. This product raises it again.
- A full inactive ingredient list, published on the product page.
- Inside that list, an antioxidant system of ascorbic acid, sodium bisulfite and butylated hydroxytoluene — which is precisely what a hydroquinone preparation needs, because hydroquinone oxidises readily and an oxidised hydroquinone is an inactive one.
- Preservatives quoted to two decimal places: benzoic acid 0.09%, sorbic acid 0.09%.
- A published fill weight of 18 g. This is the first product in sixteen reviews to state one, and it means cost per application is finally computable rather than a hole in our scoring.
- An application technique that limits treated area — cotton swab for discrete spots — which happens to address one of the three named risk factors in the ochronosis literature.
- A realistic timeline: eight to twelve weeks before dark spots lighten.
On the antioxidant point specifically: we gave a competitor genuine credit for including sodium bisulfite and BHT in its hydroquinone product, and we criticised another for describing no stability system at all. This one publishes it in the ingredient list where anybody can check.
The two gaps
No concentration is published for any active. As with this company's Future Formula, personalisation is a legitimate reason not to print a single number — but it is not a reason to withhold a range, and hydroquinone is the ingredient where the range matters most. Conventional prescription strength is 4%, and the systematic review literature finds reported ochronosis cases clustering above it. A buyer who knew they were on 4% rather than something higher would understand their own risk profile considerably better.
The product page lists five candidate actives and hydrocortisone is not among them. It appears in the company's own support material as part of the hydroquinone formula. Corticosteroids on facial skin carry real considerations — atrophy, telangiectasia, perioral dermatitis with prolonged use — and while the cycling protocol handles the duration risk well, a buyer is entitled to know a steroid is in the tube before they order it, not after.
There is a smaller point about placement. The cycling schedule is the strongest thing about this product and it lives in a support article. It should be on the product page, in the largest type available, because it is both a genuine safety feature and the best argument for buying this rather than a competitor.
The 79% claim
Seventy-nine percent of customers report the product works better than over-the-counter dark spot treatments they have tried, from a survey of 147 patients using it for nine to twelve months.
The grade is unchanged from the sibling product: a self-reported, uncontrolled, unblinded preference survey against an unspecified comparator. What continues to distinguish it is the presentation — sample size stated, duration stated, and the word survey used rather than implied. Nine to twelve months is also an honest window for pigmentation, which is slow.
Against the other hydroquinone products here
Four products in this register are built on hydroquinone. Setting them side by side shows how much of the difference is structural rather than pharmacological.
Agency does not publish its concentration and two of the others do. It still scores substantially higher, because a known concentration used indefinitely is a worse position than an unknown concentration used in enforced courses with the treated area kept small.
If you are considering it
- Ask which actives you have been prescribed, and ask specifically whether your formula contains hydrocortisone.
- Ask for the hydroquinone concentration once your first tube issues — the label carries it.
- Use the cotton swab technique for discrete spots. Smaller treated area is a genuine risk reduction, not fussiness.
- Do not try to skip the hydroquinone-free months. The break is the safety feature you are paying for.
- Wear broad-spectrum sunscreen daily without exception. Depigmenting skin and then exposing it to UV undoes the work and provokes rebound.
- Photograph the area monthly under fixed lighting. Pigment change is gradual.
- Stop and seek advice if treated skin darkens, greys or takes on a bluish cast rather than lightening.
Where we stand
This is the most interesting product in the register, because what raises it is not the formula — it is the protocol. Anyone can compound hydroquinone. Building the break into the subscription, sending the right bottle without being asked, and explaining that long-term use risks permanent discoloration is a company designing against its own short-term commercial interest.
It is a 65 rather than higher because a personalised product that will not publish its range leaves the buyer unable to weigh their own hydroquinone exposure, and because a topical corticosteroid is in the tube without being named on the page that sells it.
Publish the range, name the steroid, and move the cycling schedule onto the product page. Those three edits would make this the product we recommend for hyperpigmentation without qualification.
Who this is for
- Someone with established melasma or sun spots who wants hydroquinone used properly — in courses, with enforced breaks — without having to police the schedule themselves.
- Someone who has reacted to ingredients before and needs to check a full inactive list first.
- Someone treating discrete spots rather than a whole face, using the cotton-swab technique the page describes.
- Someone who will wear daily broad-spectrum sunscreen, without which any depigmenting treatment undoes itself.
- You are pregnant, trying to conceive, or breastfeeding — raise this at consultation.
- You want to know your exact hydroquinone concentration before committing.
- You are unwilling to accept a corticosteroid in the formula; ask directly, because the page does not name it.
- You have previously reacted to kojic acid, whose level here is unstated.
- You will not use sunscreen daily.
- You want continuous treatment with no breaks. The breaks are the point, and they are the reason this scores as well as it does.
Ask which actives you have been prescribed and whether your formula contains hydrocortisone — the product page does not name it.
This is an editorial assessment of published information about a prescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.
Sources
- S-01Agency — Dark Spot Formula product page Price, 18 g fill weight, the five-active pool, the full inactive ingredient list including the antioxidant system and quoted preservative levels, application technique, and the 79%/147-patient survey claim.
- S-02Agency support — Dark Spot Formula: what to expect The cycling schedule: two to three months on a hydroquinone and hydrocortisone formula, then two months hydroquinone-free, switched automatically; and the eight-to-twelve-week timeline.
- S-03Curology — hydroquinone: everything you need to know The company's own published position on hydroquinone supervision, prescription status and use.
- S-04Ishack et al. — exogenous ochronosis associated with hydroquinone: a systematic review Concentration, duration and treated area as the co-factors the cycling protocol is designed against.
- S-05SCCS opinion on kojic acid (SCCS/1637/21) European scientific opinion on safe use of kojic acid as a skin-lightening agent.